Mio Global Announces $15 Million USD in Series B Funding

Mio Global, known for the most accurate wrist-based heart rate technology, today announces $15M USD in funding led by Hydra Ventures with participation from private investors.
As quoted in the press release:

Recently, Mio introduced “PAI” (Personal Activity Intelligence) — a ground-breaking personal health metric that is backed by (a) leading scientific research and (b) an intelligent software platform that uses heart rate to track the body’s response to all types of physical activity while providing actionable and personalized feedback to help users maintain optimal health. PAI captures everything a user needs to know about their heart rate activity in the form of a simple score, and provides a clear actionable goal: keep your PAI score at 100 or above.
Mio will continue to draw on the expertise provided by Hydra Ventures as it scales, and the funding will be partially used to further develop Mio’s AI-based sensor analytics and insights platform within PAI that was acquired from the Nobel Prize winning Norwegian University of Science and Technology. In addition, the funding will be used to launch the Mio SLICE, which is the next generation of Mio’s best-in-class wrist-based wearables and is the first activity tracker to capture all-day heart rate data and display PAI directly on the wristband. Mio envisions that SLICE will become a strong reference design for other companies interested in licensing PAI and Mio’s highly accurate sensor IP.